Market Research Logo

Arbutus Biopharma Corporation (ABUS) - Financial and Strategic SWOT Analysis Review

Arbutus Biopharma Corporation (ABUS) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Arbutus Biopharma Corporation (Arbutus Biopharma) formerly Tekmira Pharmaceuticals Corporation, is a biopharmaceutical company which focuses on the development and commercialization of proprietary drugs and drug delivery systems indicated for the treatment of chronic hepatitis B infection. Arbutus Biopharma’s pipeline includes HBV candidates such as TKM-HBV; and OCB-030 licensed from Neurovive; CYT003 licensed from Cytos; two capsid assembly inhibitors, cccDNA epigenetic modifiers and STING agonists licensed from Blumberg and Drexel University; surface antigen secretion inhibitors obtained from the acquisition of Enantigen;. The company also has cancer, anti-viral and metabolic programs. Arbutus Biopharma develops product candidates based on its lipid nanoparticle (LNP) delivery technology. It operates in the US and Canada. Arbutus Biopharma is headquartered in British Columbia, Canada.

Arbutus Biopharma Corporation Key Recent Developments

Aug 08, 2016: Arbutus Announces Issuance of Broad New US Patent for LNP Delivery Technology
Aug 04, 2016: Arbutus Provides Corporate Update and Announces Second Quarter 2016 Financial Results
Jul 18, 2016: Arbutus to Present Data on New LNP Formulations for Delivery of mRNA at the 2016 Controlled Release Society Conference
Jun 30, 2016: Arbutus to Present mRNA Delivery Data at the 32nd Annual Meeting of the Japan Society of Drug Delivery System
May 04, 2016: Arbutus Provides Corporate Update and Announces First Quarter 2016 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Arbutus Biopharma Corporation - Key Facts
Arbutus Biopharma Corporation - Key Employees
Arbutus Biopharma Corporation - Key Employee Biographies
Arbutus Biopharma Corporation - Major Products and Services
Arbutus Biopharma Corporation - Pharmaceutical Pipeline Products Data
Arbutus Biopharma Corporation, Pipeline Products by Therapy Area
Arbutus Biopharma Corporation, Pipeline Products by Development Phase
Arbutus Biopharma Corporation - History
Arbutus Biopharma Corporation - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Arbutus Biopharma Corporation - Business Description
Arbutus Biopharma Corporation - Corporate Strategy
Arbutus Biopharma Corporation - SWOT Analysis
SWOT Analysis - Overview
Arbutus Biopharma Corporation - Strengths
Arbutus Biopharma Corporation - Weaknesses
Arbutus Biopharma Corporation - Opportunities
Arbutus Biopharma Corporation - Threats
Arbutus Biopharma Corporation - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Arbutus Biopharma Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Arbutus Biopharma Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Arbutus Biopharma Corporation, Recent Deals Summary
Section 5 – Company’s Recent Developments
Aug 08, 2016: Arbutus Announces Issuance of Broad New US Patent for LNP Delivery Technology
Aug 04, 2016: Arbutus Provides Corporate Update and Announces Second Quarter 2016 Financial Results
Jul 18, 2016: Arbutus to Present Data on New LNP Formulations for Delivery of mRNA at the 2016 Controlled Release Society Conference
Jun 30, 2016: Arbutus to Present mRNA Delivery Data at the 32nd Annual Meeting of the Japan Society of Drug Delivery System
May 04, 2016: Arbutus Provides Corporate Update and Announces First Quarter 2016 Financial Results
Apr 22, 2016: Arbutus Presents Data from Combination Activity Studies of HBV Drug Candidates
Apr 21, 2016: Arbutus Announces Planned Executive Departure
Mar 09, 2016: Arbutus Announces Year-End 2015 Financial Results
Mar 08, 2016: Arbutus Appoints Dr. Elizabeth Howard Executive Vice President and General Counsel
Jan 10, 2016: Arbutus Provides a Corporate Update and Outlines 2016 Milestones
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Arbutus Biopharma Corporation, Key Facts
Arbutus Biopharma Corporation, Key Employees
Arbutus Biopharma Corporation, Key Employee Biographies
Arbutus Biopharma Corporation, Major Products and Services
Arbutus Biopharma Corporation, Number of Pipeline Products by Therapy Area
Arbutus Biopharma Corporation, Number of Pipeline Products by Development Stage
Arbutus Biopharma Corporation, Pipeline Products By Therapy Area and Development Phase
Arbutus Biopharma Corporation, History
Arbutus Biopharma Corporation, Subsidiaries
Arbutus Biopharma Corporation, Key Competitors
Arbutus Biopharma Corporation, Ratios based on current share price
Arbutus Biopharma Corporation, Annual Ratios
Arbutus Biopharma Corporation, Interim Ratios
Arbutus Biopharma Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Arbutus Biopharma Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Arbutus Biopharma Corporation, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Arbutus Biopharma Corporation, Pipeline Products by Therapy Area
Arbutus Biopharma Corporation, Pipeline Products by Development Phase
Arbutus Biopharma Corporation, Performance Chart (2011 - 2015)
Arbutus Biopharma Corporation, Ratio Charts
Arbutus Biopharma Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Arbutus Biopharma Corporation, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report